Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE guidelines) - Inserm - Institut national de la santé et de la recherche médicale Accéder directement au contenu
Article Dans Une Revue Journal of Nuclear Medicine Année : 2022

Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE guidelines)

Résumé

An important need exists for strategies to perform rigorous objective clinical-task-based evaluation of artificial intelligence (AI) algorithms for nuclear medicine. To address this need, we propose a 4-class framework to evaluate AI algorithms for promise, technical task-specific efficacy, clinical decision making, and postdeployment efficacy. We provide best practices to evaluate AI algorithms for each of these classes. Each class of evaluation yields a claim that provides a descriptive performance of the AI algorithm. Key best practices are tabulated as the RELAINCE (Recommendations for EvaLuation of AI for NuClear medicinE) guidelines. The report was prepared by the Society of Nuclear Medicine and Molecular Imaging AI Task Force Evaluation team, which consisted of nuclear-medicine physicians, physicists, computational imaging scientists, and representatives from industry and regulatory agencies.
Fichier principal
Vignette du fichier
JNUMED-2021-263239v1-Jha.pdf (1.46 Mo) Télécharger le fichier
Origine : Fichiers produits par l'(les) auteur(s)

Dates et versions

inserm-03872921 , version 1 (26-11-2022)

Identifiants

Citer

Abhinav Jha, Tyler Bradshaw, Irène Buvat, Mathieu Hatt, Prabhat Kc, et al.. Nuclear Medicine and Artificial Intelligence: Best Practices for Evaluation (the RELAINCE guidelines). Journal of Nuclear Medicine, 2022, 63 (9), pp.1288-1299. ⟨10.2967/jnumed.121.263239⟩. ⟨inserm-03872921⟩
16 Consultations
31 Téléchargements

Altmetric

Partager

Gmail Facebook X LinkedIn More